PREPARE FOR BLAST OFF-!! Taboola.com Ltd. (TBLA) 4.0800+0.6000 (+17.2414%) As of 01:55PM EST. Market open.
WE HAVE HAD TWO GOOD BOND AUCTIONS IN A ROW. YESTERDAY'S BETTER THAN TODAY'S & I HAVE NOT HEard Rick Santelli assessment of today's (he liked yesterdays) > But stocks are clearly pinging off Bond auctions<-- when they go south so do stocks... When the auction is absorbed... WE GO UP!
The Trade Desk, Inc. (TTD) Reports after the close tomm-- I have to double check our PT-- we are going to hold our nose and HOLD in the hope of finishing our Swing trade... 78.84+1.14 (+1.47%) At close: 04:00PM EST 79.60 +0.76 (+0.96%)<-------------- After hours: 06:09PM EST
PubMatic reports Q3 EPS 21c, consensus (5c) » 17:08 PUBM PUBM PubMatic, Inc. $12.10 0.08(+0.67%)4:00 PM 11/08/23 NASDAQ |$USD |Post-Market:$14.43+2.33(+19.26%)5:58 PM
It is Thursday. DIS Beats earn. Never thought the day would come. Must be those folks dropping deuces on long lines. Disney FY24 FCF guidance 'meaningfully ahead of expectations,' says Evercore » 06:19 DIS Take Two Reports- Take-Two backs FY24 net bookings view of $5.45B-$5.55B, consensus $5.51B » 16:49 TTWO Cuts FY24 adjusted EBITDA… Twilio smashes earn Twilio jumps 7% to $59.90 after earnings beat, guidance raise 16:39 TWLO AFRM reports still losing money. Affirm reports Q1 EPS (57c), consensus (71c) » 16:33 AFRM OTHER- --Pangaea Logistics reports Q3 adjusted EPS 32c, consensus 16c » 16:32 PANL --IonQ raises FY23 revenue view to $21.2M-$22M from $18.9M-$19.3M 16:29 IONQ --IonQ sees Q4 revenue $5.3M-$6.1M, consensus $4.37M 16:28 IONQ --TTEC Holdings reports Q3 non-GAAP EPS 48c, consensus 44c » 16:28 TTEC --electroCore boosts year revenue view to $15M - $15.5M from prior $14M -$15M » 16:27 ECOR --LiveRamp sees Q3 revenue $165M, consensus $163.11M » 16:19 RAMP UPGRADE OF THE DAY- Goldman has 'increasing comfort' with Syfovre, starts Apellis at Buy » 06:27 APLS Q- WTF IS Syfovre?
Description electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults; Truvaga for the support of general health and wellbeing; and TAC-STIM, a form of nVNS for human performance. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.